Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03722264 · ClinicalTrials.gov registry record · NA
An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients
A NA study of Cavities of Teeth, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03722264 is a NA study of Cavities of Teeth that has completed, run by Virginia Commonwealth University. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03722264, a NA study of Cavities of Teeth, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Fluoride is very effective in preventing dental decay (cavities) when applied in the form of a varnish on tooth surfaces. The purpose of this study is to verify if fluoride-releasing primer (OpalSeal) offers more protection against early dental decay (cavity) compared to conventional primer (Transbond XT) during treatment with braces.
Conditions Studied
Interventions
- DEVICE OpalSeal
- DEVICE TransbondXT
Study Locations (1)
Virginia
- School of Dentistry, Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-11-16 |
| Est. Completion | 2019-04-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03722264
The ClinicalTrials.gov registry entry for NCT03722264 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cavities of Teeth appearing as the primary indexed condition, and to 2 interventions - of which OpalSeal is the first listed.
NCT03722264 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT03722264 about?
NCT03722264 is a clinical study titled "An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients". Fluoride is very effective in preventing dental decay (cavities) when applied in the form of a varnish on tooth surfaces. The purpose of this study is to verify if fluoride-releasing primer (OpalSeal) offers more protection against early dental decay (cavity) compared to conventional primer (Transbo...
What is the current status of trial NCT03722264?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-11-16. Estimated completion is 2019-04-12.
What conditions does trial NCT03722264 study?
This clinical trial studies the following conditions: Cavities of Teeth.
What interventions are being tested in trial NCT03722264?
The interventions under investigation include: OpalSeal (DEVICE), TransbondXT (DEVICE).
Who is sponsoring clinical trial NCT03722264?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03722264 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cavities of Teeth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.